Some patients with large vessel occlusion strokes may still benefit from thrombolysis even after the traditional 4.5-hour window, new analysis of the TIMELESS trial suggested.
Late tenecteplase treatment (4.5-24 hours post-stroke) did not benefit patients with large-vessel occlusion stroke, but could help those with M1 occlusions, a new study showed.
Utilizing user-friendly, swiftly applicable electrodes, subhairline EEG may improve stroke detection and reduce time to treatment for anterior circulation large vessel occlusion stroke.
Despite surgical advances, adding extracranial-intracranial bypass to medical therapy does not reduce stroke or death in symptomatic occlusion of the internal carotid or middle cerebral artery.
Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial, although there were some encouraging findings.